about
Mesenchymal stem cells as therapeutic target of biophysical stimulation for the treatment of musculoskeletal disordersDose-Related and Time-Dependent Development of Collagenase-Induced Tendinopathy in RatsBlood management and transfusion strategies in 600 patients undergoing total joint arthroplasty: an analysis of pre-operative autologous blood donation.Fabrication of Innovative Silk/Alginate Microcarriers for Mesenchymal Stem Cell Delivery and Tissue Regeneration.High Levels of Circulating Type II Collagen Degradation Marker (CTx-II) Are Associated with Specific VDR Polymorphisms in Patients with Adult Vertebral Osteochondrosis.Validation of the Italian version of the Oxford Ankle Foot Questionnaire for children.Silk/Fibroin Microcarriers for Mesenchymal Stem Cell Delivery: Optimization of Cell Seeding by the Design of ExperimentVitamin D's Effect on the Proliferation and Inflammation of Human Intervertebral Disc Cells in Relation to the Functional Vitamin D Receptor Gene FokI PolymorphismIn vitro functional response of human tendon cells to different dosages of low-frequency pulsed electromagnetic fieldMultidifferentiation potential of human mesenchymal stem cells from adipose tissue and hamstring tendons for musculoskeletal cell-based therapySoft-Focused Extracorporeal Shock Waves Increase the Expression of Tendon-Specific Markers and the Release of Anti-inflammatory Cytokines in an Adherent Culture Model of Primary Human Tendon CellsLow Frequency Pulsed Electromagnetic Field Affects Proliferation, Tissue-Specific Gene Expression, and Cytokines Release of Human Tendon CellsIn Vitro Induction of Tendon-Specific Markers in Tendon Cells, Adipose- and Bone Marrow-Derived Stem Cells is Dependent on TGFβ3, BMP-12 and Ascorbic Acid StimulationIdentification of miRNA Reference Genes in Extracellular Vesicles from Adipose Derived Mesenchymal Stem Cells for Studying OsteoarthritisAutologous Matrix-Induced Chondrogenesis (AMIC) and AMIC Enhanced by Autologous Concentrated Bone Marrow Aspirate (BMAC) Allow for Stable Clinical and Functional Improvements at up to 9 Years Follow-Up: Results from a Randomized Controlled StudyInteraction with hyaluronan matrix and miRNA cargo as contributors for in vitro potential of mesenchymal stem cell-derived extracellular vesicles in a model of human osteoarthritic synoviocytesInsights into Inflammatory Priming of Adipose-Derived Mesenchymal Stem Cells: Validation of Extracellular Vesicles-Embedded miRNA Reference Genes as A Crucial Step for Donor Selection.Onsets of complications and revisions are not increased after simultaneous bilateral unicompartmental knee arthroplasty in comparison with unilateral proceduresPlasma vitamin D and osteo-cartilaginous markers in Italian males affected by intervertebral disc degeneration: Focus on seasonal and pathological trend of type II collagen degradationSecreted Factors and EV-miRNAs Orchestrate the Healing Capacity of Adipose Mesenchymal Stem Cells for the Treatment of Knee OsteoarthritisLymphatic Cannulation for Lymph Sampling and Molecular DeliveryEvaluation of Different Seeding Methods for Cell-Seeded Collagen Matrix-Supported Autologous Chondrocyte TransplantationAutologous Microfragmented Adipose Tissue Reduces the Catabolic and Fibrosis Response in an In Vitro Model of Tendon Cell InflammationHuman Diseased Articular Cartilage Contains a Mesenchymal Stem Cell-Like Population of Chondroprogenitors with Strong Immunomodulatory ResponsesInflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint diseasePain and Functional Scores in Patients Affected by Knee OA after Treatment with Pulsed Electromagnetic and Magnetic Fields: A Meta-Analysis
P50
Q28073614-D01E5D58-3578-4787-8A60-12BDFD6E4390Q36108944-B61536CD-A664-466C-90F7-C964994264A5Q37059209-2E49550D-D38E-4582-A125-BA4AA86E5BBDQ41661389-07152AE0-BE93-4114-8074-E37F05B1AA3CQ43554558-9DD442C3-C6E8-4B61-B282-FDC2E2AC06EDQ48012113-D3DE3F8A-8251-4AD9-9758-8ADC4C59B2D6Q57794005-62F29608-91EB-4191-99F0-803A68B8D0F6Q57997372-3262C288-7D18-4B0A-95C7-D813887990A1Q57997398-FADBAA6C-3A25-4C94-A763-58B03241C968Q57997406-5E276AEA-913A-4EF3-A8DC-44CE6A46B5AFQ57997418-ACB26D1D-7E57-461A-9482-1B47C2B64E92Q57997426-9CD9CF75-4AD4-4C16-8629-C7CD80D68ADFQ60921596-8E476C70-D905-4A8D-BCCD-7339AA3EF628Q64063282-3B87C1D2-0723-4FCC-953D-B165520C6EDEQ64066036-D5E96C54-305A-4A8B-9BAC-B54E000A3406Q64105550-B42DE3CB-1E19-4F78-A77A-0355C7A8F56DQ64968451-44CEED79-C306-4AF3-9A76-846868EC9380Q85777100-CA2DFEFD-3789-440A-846B-A639A38EB00DQ88155509-BDBC7E50-39EA-4FBD-9D64-38A2EAFA2D96Q89944473-9C3C608E-25D7-4EFF-A82F-8465D062E101Q90100470-D1C17538-746C-4BA5-88A1-AB57A699009EQ92268281-A358D66E-BE80-4925-92CE-7F0AD4C17CAEQ92308057-1078810A-DAC9-48DF-AA12-AB09B75A258AQ92701789-E8CE860C-9296-4D33-BD5B-64CB3CE0271CQ94450959-8A42A46B-B127-4B5F-B550-81634F183BEAQ96167674-9D804DAD-EA2F-44AE-A248-E0EF97456489
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marco Viganò
@ast
Marco Viganò
@en
Marco Viganò
@es
Marco Viganò
@nl
type
label
Marco Viganò
@ast
Marco Viganò
@en
Marco Viganò
@es
Marco Viganò
@nl
prefLabel
Marco Viganò
@ast
Marco Viganò
@en
Marco Viganò
@es
Marco Viganò
@nl
P106
P1153
55560167200
P31
P496
0000-0002-6463-6564